An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome

被引:0
作者
Hang Hu
Xindong Jin
Hongfei Jiang
Xinlei Hu
Chunmao Han
机构
[1] Zhejiang University Hangzhou,Department of Burns and wound center, second affiliated Hospital, school of medicine
[2] Zhejiang Institute of Dermatology,Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, school of Medicine
[3] Zhejiang University,undefined
来源
International Journal of Diabetes in Developing Countries | 2013年 / 33卷
关键词
Diabetes; Diabetic foot; Advanced glycation end-product; Autofluorescence; Follow up;
D O I
暂无
中图分类号
学科分类号
摘要
To determine the risk factors of foot ulcers in diabetic patients indirectly via the measurement of advanced glycation end-products (AGE) with autofluorescence (AF). Between 2008 and 2009, a total of 195 diabetic inpatients, were recruited. Patients were categorized into those without foot ulcer, or with foot ulcer. Patients were followed up for 1 year via telephone and hospital visit. According to the first screening, mean values of skin AF were:2.29 ± 0.47 for subjects without foot ulcers and 2.80 ± 0.69 for those with foot ulcers, a significant difference(P < 0.05). Follow-up was conducted via telephone in 149 patients, and there were no significant changes in disease condition of both groups. Additionally, 34 patients were further followed-up via hospital visit. Each variable of these patients after follow-up was closely related to the corresponding one before follow-up (P < 0.05). Glycosylated hemoglobin (HbA1c) levels markedly declined, and high-density lipoprotein (HDL) cholesterol levels and VPT were significantly increased, after follow-up (P < 0.05). Moreover, there were no significant changes in AF value and ABI during follow-up. AF, which is associated with in vivo AGE levels, is also closely related to various risk factors of foot ulcers in diabetic patients. Our follow-up duration was relatively short, and thus, more studies with longer follow-up periods are warranted to confirm the role of AF as a risk factor for foot ulcers in diabetic patients.
引用
收藏
页码:18 / 22
页数:4
相关论文
共 38 条
[1]  
Frykberg RG(2006)Diabetic foot disorders. A clinical practice guideline (2006 revision) J Foot Ankle Surg 45 S1-66
[2]  
Zgonis T(2008)Advanced glycation end products and diabetic foot disease Diabetes Metab Res Rev 24 S19-24
[3]  
Armstrong DG(2008)10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 1577-89
[4]  
Driver VR(2002)Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo Am J Pathol 161 531-41
[5]  
Giurini JM(2002)Advanced glycation end product precursors impair epidermal growth factor receptor signaling Diabetes 51 1535-42
[6]  
Kravitz SR(2001)Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice Am J Pathol 159 513-25
[7]  
Huijberts MS(2003)Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice Diabetes 52 2805-13
[8]  
Schaper NC(undefined)undefined undefined undefined undefined-undefined
[9]  
Schalkwijk CG(undefined)undefined undefined undefined undefined-undefined
[10]  
Holman RR(undefined)undefined undefined undefined undefined-undefined